Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Rudy Saucillo who wrote (1199)	6/23/1998 2:09:00 PM
From: Steve Harmon	Read Replies (1) \| Respond to of 2742

Rudy, Agreed on the Bluestone timeframe...now in its 10th month>>>> NO results NO stock support. Shareholder value cut in HALF. Bluestone Capital has already been given $90,000 and 400,000 dirt cheap shares at 25 cents. It seems like everyone associated with Cistron>>>the management, Bluestone Capital, newly hired scientists are getting great deals and payoffs....while the shareholders are getting no results!

To: Rudy Saucillo who wrote (1199)	6/23/1998 8:55:00 PM
From: Walter Morton	Read Replies (1) \| Respond to of 2742

Why are you sending Messages to yourself? Send the messages to CIST. I have sent them a merger suggestions that they responded to in a very professional manner. I must admit that the stock that I suggested went from $.08 to about $.5 (VODG). It was turned down for what seemed to be a very good reason. I believe that if you ask these business men (via e-mail), with a hint of respect, why they did not do the deals that you recommended, they would give you a reason that you can post here. I believe that their explanation would be much more useful to all. If you have already tried this approach, please accept may apology.